The prognostic significance of extramural deposits and extracapsular lymph node invasion in colon cancer

Diseases of the Colon and Rectum

Volumn 54, Issue 8, 2011, Pages 982-988

  Al Sahaf, Osama ^a   Myers, Eddie ^a   Jawad, Mohamed ^a   Browne, Tara J ^a   Winter, Desmond C ^b   Redmond, Henry P ^a  

^a University College Cork and INFANT Centre   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Colon cancer; Extracapsular lymph node invasion; Extramural deposits

Indexed keywords

AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COLON CANCER; DISEASE FREE SURVIVAL; DISEASE SEVERITY; EXTRACAPSULAR LYMPH NODE INVASION; EXTRAMURAL DEPOSIT; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; OVERALL SURVIVAL; PROGNOSIS; RISK ASSESSMENT; SURVIVAL TIME; TUMOR VOLUME;

AGED; COLONIC NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 80052717175     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0b013e31821c4944     Document Type: Article

References (28)

1. Rosenberg R, Friederichs J, Schuster T, et al. Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period. Ann Surg. 2008;248:968-978.
2. Fleming ID, Cooper JS, Henson DE, et al, eds. AJCC Cancer Staging Manual. 5th ed. Philadelphia, PA: Lippincott-Raven Publishers; 1997.
3. Edge S, Page DL, Balch CM, Fleming ID, Morrow M, eds. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer; 2009.
4. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A III, eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010.
5. Nagtegaal ID, Quirke P. Colorectal tumour deposits in the mesorectum and pericolon: a critical review. Histopathology. 2007; 51:141-149. (Pubitemid 47083979)
6. Nagtegaal ID, Quirke P. Revised staging, is it really better, or do we not know. J Clin Oncol. 2010;28:e397-e398.
7. Wind J, ten Kate FJ, Kiewiet JJ, et al. The prognostic significance of extra-capsular lymph node involvement in node positive patients with colonic cancer. Eur J Surg Oncol. 2007;33:401-408.
8. Bosman FT. Prognostic value of pathological characteristics of colorectal cancer. Eur J Cancer. 1995;31:1216-1221.
9. van der Gaag NA, ten Kate FJ, Lagarde SM, Busch OR, van Gulik TM, Gouma DJ. Prognostic significance of extra-capsular lymph node involvement in patients with adenocarcinoma of the ampulla of Vater. Br J Surg 2008;95:735-743.
10. Fleischmann A, Thalmann GN, Markwalder R, Studer UE. Prognostic implications of extracapsular extension of pelvic lymph node metastases in urothelial carcinoma of the bladder. Am J Surg Pathol. 2005;29:89-95. (Pubitemid 40023955)
11. Griebling TL, Ozkutlu D, See WA, Cohen MB. Prognostic implications of extracapsular extension of lymph node metastases in prostate cancer. Mod Pathol. 1997;10:804-809. (Pubitemid 27374851)
12. Prabhudesai A, Arif S, Finlayson CJ, Kumar D. Impact of microscopic extranodal tumor deposits on the outcome of patients with rectal cancer. Dis Colon Rectum. 2003;46:1531-1537. (Pubitemid 37429736)
13. Yamagata K, Kumagai K. Experimental study of lymphogenous peritoneal cancer dissemination: migration of fluorescent-labelled tumor cells in a rat model of mesenteric lymph vessel obstruction. J Exp Clin Cancer Res. 2000;19:211-217. (Pubitemid 30490163)
14. Burn JI. Obstructive lymphopathy. Ann R Coll Surg Engl. 1968; 42:93-113.
15. Yano H, Saito Y, Kirihara Y, Takashima J. Tumor invasion of lymph node capsules inpatients with DukesC colorectal adenocarcinoma. Dis Colon Rectum. 2006;49:1867-1877. (Pubitemid 44853444)
16. van derVelden J, van Lindert AC, Lammes FB. Extracapsular growth of lymph node metastases in squamous cell carcinoma of the vulva: the impact on recurrence and survival. Cancer. 1995;75:2885-2890.
17. Yamagata K, Kumagai K, Shimizu K, Masuo K, Nishida Y, Yasui A. Gastrointestinal cancer metastasis and lymphogenous spread: viewpoint of animal models of lymphatic obstruction. Jpn J Clin Oncol. 1998;28:104-106. (Pubitemid 128526029)
18. Lee HY, Choi HJ, Park KJ. Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma. Ann Surg Oncol. 2007;14:1712-1717.
19. Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol. 2003;21:2912-2919. (Pubitemid 46621841)
20. Swanson RS, Compton CC, Stewart AK, Bland KI. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol. 2003;10:65-71.
21. Joseph NE, Sigurdson ER, Hanlon AL, et al. Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection. Ann Surg Oncol. 2003; 10:213-218. (Pubitemid 40486952)
22. Bando E, Yonemura Y, Taniguchi K, Fushida S, Fujimura T, Miwa K. Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol. 2002;9:775-784.
23. Berger AC, Sigurdson ER, LeVoyer T, et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol. 2005;23:8706-8712. (Pubitemid 46211514)
24. Peng J, Xu Y, Guan Z, et al. Prognostic significance of metastatic lymph node ratioin node-positive rectal cancer. Ann Surg Oncol. 2008;15:3118-3123.
25. Wang J, Hassett JM, Dayton MJ, Kulaylat MN. Lymph node ratio: role in the staging of node-positive colon cancer. Ann Surg Oncol. 2008;15:1600-1608.
26. Wolpin BM, Mayer RJ. Systemic treatment of colorectal cancer. Gastroenterology. 2008;134:1296-1310.
27. Gravalos C, Garcia-Escobar I, Garcia-Alfonso P, Cassinello J, Malón D, Carrato A. Adjuvant chemotherapy for stages II, III and IV of colon cancer. Clin Transl Oncol. 2009;11:526-533.
28. Belt EJ, Van Stijn MF, Bril H, et al. Lymph node negative colorectal cancers with isolated tumour deposits should be classified and treated as stage III. Ann Surg Oncol. 2010;17: 3208-3211.